Jamie C. Riches

Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

Yelena Y. Janjigian, Francisco Sánchez-Vega, Philip Jonsson et al. · Cancer Discovery · 2017 · 382 citations · Full text

Medicine, Oncology, Immunotherapy +8

Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer

Andrea B. Apolo, Jamie C. Riches, Heiko Schöder et al. · Journal of Clinical Oncology · 2010 · 181 citations · Full text

Medicine, Oncology, Radiology +15

Phase II Study of Sunitinib in Patients With Metastatic Urothelial Cancer

David Gallagher, Matthew I. Milowsky, Scott R. Gerst et al. · Journal of Clinical Oncology · 2010 · 179 citations · Full text

Medicine, Oncology, Pharmacology +16

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer

Gopa Iyer, Arjun Vasant Balar, Matthew I. Milowsky et al. · Journal of Clinical Oncology · 2018 · 143 citations

Medicine, Oncology, Urology +17

Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy

Andrea B. Apolo, Irina Ostrovnaya, Susan Halabi et al. · JNCI Journal of the National Cancer Institute · 2013 · 94 citations · Full text

Medicine, Biostatistics, Oncology +14